All-extremity Exercise During Breast Cancer Chemotherapy
Part of paid clinical trials in Gainesville, Florida.
- Sponsor
- University of Florida
- Study ID
- NCT04914663
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Exercise training — BEHAVIORALExercise training performed at home under remote live supervision over 12 weeks while patients undergo chemotherapy for breast cancer.
Study Details
Currently, there are 3.5 million breast cancer survivors in the United States and this number is expected to increase dramatically. The proposed research will examine whether a novel exercise intervention for breast cancer patients who are undergoing chemotherapy protects against cardiovascular dysfunction. Findings may have implications for cardiovascular disease prevention in this population.
Key Dates
- Start date
- Apr 5, 2024
- Status verified
- Aug 2025
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 68 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: All-extremity exercise
- Active Comparator: Treadmill exercise
- No Intervention: Usual Care
Primary Outcome Measure
Change in brachial artery FMD [ Time Frame: 12 weeks ]
Central Contacts
- Demetra Christou, PhD3522941746
- Eileen Handberg352-273-9082
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Integrative Cardiovasculal Physiology Laboratory, University of Florida | Gainesville | Florida | 32611 |
Find similar trials in Gainesville, FL
By condition
By specialty
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Women Informed to Screen Depending on Measures of Risk (Wisdom Study)Recruiting · University of California, San Francisco · Birmingham, Alabama
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Birmingham, Alabama